GSA Capital Partners LLP Sells 13,679 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

GSA Capital Partners LLP lessened its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 25.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 39,925 shares of the company's stock after selling 13,679 shares during the quarter. GSA Capital Partners LLP owned about 0.08% of Prestige Consumer Healthcare worth $2,879,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Ariel Investments LLC raised its stake in Prestige Consumer Healthcare by 10.7% in the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company's stock worth $195,204,000 after purchasing an additional 274,212 shares in the last quarter. Victory Capital Management Inc. raised its stake in Prestige Consumer Healthcare by 9.0% in the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company's stock worth $142,827,000 after purchasing an additional 171,357 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in Prestige Consumer Healthcare by 19.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company's stock worth $113,570,000 after purchasing an additional 255,045 shares in the last quarter. Congress Asset Management Co. raised its stake in Prestige Consumer Healthcare by 7.8% in the 3rd quarter. Congress Asset Management Co. now owns 865,123 shares of the company's stock worth $62,375,000 after purchasing an additional 62,411 shares in the last quarter. Finally, Boston Trust Walden Corp bought a new position in Prestige Consumer Healthcare in the 3rd quarter valued at about $41,785,000. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Down 0.0 %

Shares of NYSE PBH traded down $0.04 during midday trading on Tuesday, reaching $81.71. The stock had a trading volume of 517,308 shares, compared to its average volume of 249,327. The firm has a market cap of $4.04 billion, a price-to-earnings ratio of 20.00, a price-to-earnings-growth ratio of 2.27 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $82.82. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.90 and a current ratio of 3.56. The company's 50 day moving average price is $72.69 and its 200 day moving average price is $69.92.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.09. The firm had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company's revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.07 EPS. As a group, sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.44 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Jefferies Financial Group reaffirmed a "hold" rating and set a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reiterated a "buy" rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.